A hub for independent voices and hard truths
Pfizer beats out Novo with $10B agreement to buy Metsera After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has prevailed in its pursuit of obesity biotech …
https://invezz.com/news/2025/09/22/pfizer-close-to-acquiring-metsera-for-7-3b-targeting-breakthrough-obesity-drug/ Pfizer nears $7.3B deal to acquire Metsera, targeting next-gen obesity treatments. MET-097i shows 11.3% weight loss in trials and offers monthly dosing. Acquisition positions Pfizer against Novo Nordisk and Eli Lilly in obesity market. Pfizer is making a bold …